![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/18 | (2006.01) |
A61K 47/183 | (2013.01) | ||
A61K 47/20 | (2006.01) | ||
A61K 47/26 | (2013.01) | ||
A61P 7/06 | (2006.01) | ||
A61K 9/19 | (2013.01) | ||
A61P 37/02 | (2006.01) | ||
A61K 38/1816 | (2013.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 47/20 | (2013.01) | ||
A61K 9/19 | (2006.01) | ||
A61P 37/02 | (2018.01) | ||
A61K 47/18 | (2017.01) | ||
A61P 7/06 | (2018.01) |
(11) | Number of the document | 3160511 |
(13) | Kind of document | T |
(96) | European patent application number | 15738505.5 |
Date of filing the European patent application | 2015-06-15 | |
(97) | Date of publication of the European application | 2017-05-03 |
(45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2015/035884 |
Date | 2015-06-15 |
(87) | Number | WO 2015/200027 |
Date | 2015-12-30 |
(30) | Number | Date | Country code |
201462017560 P | 2014-06-26 | US |
(72) |
PARK, Sungae , US
MCAULEY, Arnold J. , US
|
(73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
(54) | PROTEIN FORMULATIONS |
PROTEIN FORMULATIONS |